Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Human myelin proteome and comparative analysis with mouse myelin.
Enhancing our understanding of white matter changes in early multiple sclerosis.
Anxiety, depression and fatigue at 5-year review following CNS demyelination.
Occupational Therapy Interventions for Adults With Multiple Sclerosis.
Data Quality Challenges in Systemic Lupus Erythematosus Trials: How Can This Be Optimized?
Cytoskeletal Linker Protein Dystonin Is Not Critical to Terminal Oligodendrocyte Differentiation or CNS Myelination.
Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5).
Experimental autoimmune encephalomyelitis and age-related correlations of NADPH oxidase, MMP-9, and cell adhesion molecules: The increased disease severity and blood-brain barrier permeability in middle-aged mice.
What you cannot get from routine MRI of MS patient and why - The growing need for atrophy assessment and seeing beyond the plaque.
Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
Hypoxia-inducible factor 1 in autoimmune diseases.
The adaptive immune response in celiac disease.
Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunction.
Influence of Formal Education on Cognitive Reserve in Patients with Multiple Sclerosis.
Considering depression as a consequence of activation of the inflammatory response system.
Microglial priming through the lung-brain axis: the role of air pollution-induced circulating factors.
Targeting specific cells in the brain with nanomedicines for CNS therapies.
GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage.
Environmental enrichment as a method to improve cognitive function. What can we learn from animal models?
Vitamin D in the healthy and inflamed central nervous system: access and function.
A Comparison of Stated Preferences for Injectable Disease-Modifying Treatments for Multiple Sclerosis: Compliant Vs. Non-Compliant Patients.
Comparison of Network Meta-Analysis and Traditional Meta-Analysis for Prevention of Relapses In Multiple Sclerosis.
[Current and historical concept of neuromyelitis optica].
Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis.
Age-specific localization of NMDA receptors on oligodendrocytes dictates axon function recovery after ischemia.
Pages
« first
‹ previous
…
677
678
679
680
681
682
683
684
685
…
next ›
last »